Although his antinuclear antibody (ANA) status throughout this period is not known, he had no clinical features suggestive of systemic lupus erythematosus (SLE). On admission to hospital ...

Less than 1% of healthy individuals had a positive result, and over 95% who demonstrated the LE cell phenomena had either systemic lupus erythematosus (SLE), scleroderma or rheumatoid arthritis.

UCB and Biogen’s drug dapirolizumab pegol has met the primary endpoint of improvement in disease activity in lupus patients.

The following is a summary of “Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus,” ...

Preconception predictors of adverse pregnancy outcomes among women with SLE include previous lupus nephritis, chronic hypertension, SLE disease activity, and APS.

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...

The study involved 945 patients with SLE (median disease duration, 1.0 year), including 113 men and 832 women aged an average of 29.0 years. The roles of antibodies and complement components in ...

In the Phase III REGENCY study, Gazyva elicited superior complete renal response rates in patients with lupus nephritis ...

The following is a summary of “Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes,” published in the September 2024 issue of Obstetrics and Gynecology by Moyle et al.

A new chapter may have begun in the exciting story of "immune reset" therapy for difficult-to-treat autoimmune diseases, with ...

Antivenom (often spelled “antivenin”) is an antibody product that can disable a particular venom’s toxins. If injected quickly after a bite or sting, the antibodies in antivenom neutralize the venom, ...

The study finds a significant correlation between premature ovarian insufficiency and autoimmune diseases, urging further ...